These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7469847)

  • 1. Clinical features of Meige's disease (idiopathic orofacial dystonia): a report of 17 cases.
    Tolosa ES
    Arch Neurol; 1981 Mar; 38(3):147-51. PubMed ID: 7469847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): clinical aspects.
    Tolosa E; Martí MJ
    Adv Neurol; 1988; 49():73-84. PubMed ID: 3278555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blepharospasm--oromandibular dystonia (Meige's syndrome) misdiagnosed as secondary hemifacial spasm.
    Gottlieb JS; May M
    Am J Otol; 1984 Jan; 5(3):206-10. PubMed ID: 6720874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential blepharospasm and related dystonias.
    Jordan DR; Patrinely JR; Anderson RL; Thiese SM
    Surv Ophthalmol; 1989; 34(2):123-32. PubMed ID: 2686056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silent event-related fMRI reveals deficient motor and enhanced somatosensory activation in orofacial dystonia.
    Dresel C; Haslinger B; Castrop F; Wohlschlaeger AM; Ceballos-Baumann AO
    Brain; 2006 Jan; 129(Pt 1):36-46. PubMed ID: 16280353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered functional connectivity in blepharospasm/orofacial dystonia.
    Jochim A; Li Y; Gora-Stahlberg G; Mantel T; Berndt M; Castrop F; Dresel C; Haslinger B
    Brain Behav; 2018 Jan; 8(1):e00894. PubMed ID: 29568690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blepharospasm and oromandibular dystonia (Meige's syndrome) in sisters.
    Nutt JG; Hammerstad JP
    Ann Neurol; 1981 Feb; 9(2):189-91. PubMed ID: 7235635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and electrophysiological study of idiopathic orofacial dystonia (Meige's disease or Brueghel syndrome)].
    Castillo J; Castro A; Dapena D; Arias M; Colell S; Lema M; Noya M
    Rev Clin Esp; 1984 Apr; 173(2):85-9. PubMed ID: 6739909
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuropharmacological profile of Meige's disease: overview and a case report.
    Ortiz A
    Clin Neuropharmacol; 1983; 6(4):297-304. PubMed ID: 6661728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal cranial dystonia.
    Golper LA; Nutt JG; Rau MT; Coleman RO
    J Speech Hear Disord; 1983 May; 48(2):128-34. PubMed ID: 6621003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meige's syndrome: History, epidemiology, clinical features, pathogenesis and treatment.
    Pandey S; Sharma S
    J Neurol Sci; 2017 Jan; 372():162-170. PubMed ID: 28017205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin secretion and the pathophysiology of Meige's disease (idiopathic orofacial dystonia): a hypothesis.
    Sandyk R; Kay SR
    Funct Neurol; 1990; 5(2):165-70. PubMed ID: 1977665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and demographic features of Meige's syndrome.
    Sharma AK; Behari M; Ahuja GK
    J Assoc Physicians India; 1996 Sep; 44(9):645-7. PubMed ID: 9251378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of onabotulinum toxin type A injections in patients with Meige's syndrome.
    Duarte A; Coutinho L; Germiniani FMB; Teive HAG
    Arq Neuropsiquiatr; 2024 Apr; 82(4):1-7. PubMed ID: 38641339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
    Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC
    Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiology and differential diagnosis of blepharospasm and oromandibular dystonia.
    Jankovic J
    Adv Neurol; 1988; 49():103-16. PubMed ID: 3278535
    [No Abstract]   [Full Text] [Related]  

  • 17. Meige's syndrome: clinical, pharmacological and radiological observations.
    Chopra JS; Radhakrishnan K; Sridharan R
    Clin Neurol Neurosurg; 1981; 83(3):145-52. PubMed ID: 6274556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic characteristics of Meige dystonia: differentiation from tardive dyskinesia.
    Stahl SM; Yesavage JA; Berger PA
    J Clin Psychiatry; 1982 Nov; 43(11):445-6. PubMed ID: 7174619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meige's syndrome.
    Ashizawa T; Patten BM; Jankovic J
    South Med J; 1980 Jul; 73(7):863-6. PubMed ID: 7384844
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.